Quantify any protein, in any sample, with any modification, without antibodies
Target Sufficiency® enables direct, quantitative analysis of drug target systems in cells, biofluids, tissues, and tissue models, including formalin-fixed, paraffin-embedded (FFPE) tissues.
Inotiv provides the broadest range of research models and related services to pharmaceutical and biotech companies, government, academia, and other life science organizations.
March 6, 2025 11 am–12 pm EDT Online webinar Lipid nanoparticles (LNPs) have emerged as popular vehicles for delivering various types of drugs such as mRN...
March 10-14, 2025 San Diego, CA Booth #5101 The Annual Meeting is where you learn first-hand from leaders in the field through interactive, engaging sessions. It's the place to get...
March 16-20, 2025 Orlando, FL Booth #621 Toxicologists and scientists will attend the annual ToxExpo to communicate industry-leading ideas and best practices. With live, semi-live,...
December 30, 2024 WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
Due to the current FDA concern and guidance on reducing the risk of Nitrosamine impurities in human drugs, there has been an increased industry need for testing of these impurities using the Bacterial Reverse Mutation (Ames) test. As Nitrosamines are not readily detectable by standard Ames methodologies, specifically cited in the Ames testing guideline (OECD 471), the need for a robust protocol better suited for this class of compounds is warranted.
General Toxicology
Histology
Pathology
DMPK
Consulting
Research Models
Research Model Services
Teklad Diet and Bedding
